SEC Form D · filed October 11, 2022
Anebulo Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Kenneth R. Lin · Lakeway, TXDirectorKenneth C. Cundy · Lakeway, TXExecSimon Allen · Chicago, ILExec · DirectorJames R. Merchant · Lakeway, TXExecJason R. Aryeh · New Hope, PADirectorKarah R. Parschauer · Lakeway, TXDirectorJason R. Aryeh · New Hope, PADirectorVanessa L. Clark · Denver, CODirectorSimon Allen · Chicago, ILExec · DirectorJames R. Merchant · Lakeway, TXExecKarah R. Parschauer · Lakeway, TXDirectorLauren Hunter · Columbus, OHDirectorKenneth C. Cundy · Lakeway, TXExecAreta R. Kupchyk · Lakeway, TXDirectorLew Lawrick · Mississauga, Ontario, CanadaDirectorJoseph F. Lawler · Lakeway, TXDirectorKenneth R. Lin · Lakeway, TXDirectorCody Church · Calgary, Alberta, CanadaDirectorAreta R. Kupchyk · Lakeway, TXDirectorAron R. English · Lakeway, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗